<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Aspirin as adjunctive treatment for giant cell arteritis - Mollan, SP - 2014 | Cochrane Library</title> <meta content="Aspirin as adjunctive treatment for giant cell arteritis - Mollan, SP - 2014 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010453.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Aspirin as adjunctive treatment for giant cell arteritis - Mollan, SP - 2014 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010453.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD010453.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Aspirin as adjunctive treatment for giant cell arteritis" name="citation_title"/> <meta content="Susan P Mollan" name="citation_author"/> <meta content="Queen Elizabeth Hospital" name="citation_author_institution"/> <meta content="soozmollan@doctors.org.uk" name="citation_author_email"/> <meta content="Noor Sharrack" name="citation_author"/> <meta content="Medical School, University of Birmingham" name="citation_author_institution"/> <meta content="Mike A Burdon" name="citation_author"/> <meta content="Queen Elizabeth Hospital" name="citation_author_institution"/> <meta content="Alastair K Denniston" name="citation_author"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="8" name="citation_issue"/> <meta content="10.1002/14651858.CD010453.pub2" name="citation_doi"/> <meta content="2014" name="citation_date"/> <meta content="2014/08/03" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010453.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010453.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010453.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Anti‐Inflammatory Agents, Non‐Steroidal [administration &amp; dosage, *therapeutic use]; Aspirin [administration &amp; dosage, *therapeutic use]; Chemotherapy, Adjuvant [methods]; Giant Cell Arteritis [*drug therapy]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010453.pub2&amp;doi=10.1002/14651858.CD010453.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010453.pub2&amp;doi=10.1002/14651858.CD010453.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010453.pub2&amp;doi=10.1002/14651858.CD010453.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010453.pub2&amp;doi=10.1002/14651858.CD010453.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010453.pub2&amp;doi=10.1002/14651858.CD010453.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010453.pub2&amp;doi=10.1002/14651858.CD010453.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010453.pub2&amp;doi=10.1002/14651858.CD010453.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010453.pub2&amp;doi=10.1002/14651858.CD010453.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010453.pub2&amp;doi=10.1002/14651858.CD010453.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010453.pub2&amp;doi=10.1002/14651858.CD010453.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010453.pub2&amp;doi=10.1002/14651858.CD010453.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010453.pub2&amp;doi=10.1002/14651858.CD010453.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010453.pub2&amp;doi=10.1002/14651858.CD010453.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010453.pub2&amp;doi=10.1002/14651858.CD010453.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010453.pub2&amp;doi=10.1002/14651858.CD010453.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010453.pub2&amp;doi=10.1002/14651858.CD010453.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010453.pub2&amp;doi=10.1002/14651858.CD010453.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010453.pub2&amp;doi=10.1002/14651858.CD010453.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010453.pub2&amp;doi=10.1002/14651858.CD010453.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010453.pub2&amp;doi=10.1002/14651858.CD010453.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010453.pub2&amp;doi=10.1002/14651858.CD010453.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010453.pub2&amp;doi=10.1002/14651858.CD010453.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010453.pub2&amp;doi=10.1002/14651858.CD010453.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="jxlIh5Me";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD010453\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD010453\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010453\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010453\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","hr","fr","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD010453.pub2",title:"Aspirin as adjunctive treatment for giant cell arteritis",firstPublishedDate:"Aug 3, 2014 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Eyes and Vision Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=jxlIh5Me&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010453.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010453.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD010453.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD010453.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010453.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD010453.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010453.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD010453.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010453.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD010453.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD010453.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD010453.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD010453.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD010453.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>4162 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD010453.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010453.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010453.pub2/full#CD010453-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010453.pub2/full#CD010453-sec-0083"> Authors' conclusions </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010453.pub2/full#CD010453-sec-0022"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010453.pub2/full#CD010453-sec-0034"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010453.pub2/full#CD010453-sec-0035"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010453.pub2/full#CD010453-sec-0070"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010453.pub2/full#CD010453-sec-0077"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD010453.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010453.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010453.pub2/appendices#CD010453-sec-0087"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010453.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010453.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010453.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010453.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010453.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010453.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD010453.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2014 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD010453.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Aspirin as adjunctive treatment for giant cell arteritis</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010453.pub2/information#CD010453-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Susan P Mollan</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010453.pub2/information#CD010453-cr-0003">Noor Sharrack</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010453.pub2/information#CD010453-cr-0004">Mike A Burdon</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010453.pub2/information#CD010453-cr-0005">Alastair K Denniston</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD010453.pub2/information/en#CD010453-sec-0097">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 03 August 2014 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD010453.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD010453.pub2">https://doi.org/10.1002/14651858.CD010453.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD010453-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010453-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010453-abs-0003">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010453-abs-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD010453-abs-0002">Français</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD010453-abs-0001" lang="en"> <section id="CD010453-sec-0001"> <h3 class="title" id="CD010453-sec-0001">Background</h3> <p>Giant cell arteritis (GCA) is a common inflammatory condition that affects medium and large‐sized arteries and can cause sudden, permanent blindness. At present there is no alternative to early treatment with high‐dose corticosteroids as the recommended standard management. Corticosteroid‐induced side effects can develop and further disease‐related ischaemic complications can still occur. Alternative and adjunctive therapies are sought. Aspirin has been shown to have effects on the immune‐mediated inflammation in GCA, hence it may reduce damage caused in the arterial wall. </p> </section> <section id="CD010453-sec-0002"> <h3 class="title" id="CD010453-sec-0002">Objectives</h3> <p>To assess the safety and effectiveness of low‐dose aspirin, as an adjunctive, in the treatment of giant cell arteritis (GCA). </p> </section> <section id="CD010453-sec-0003"> <h3 class="title" id="CD010453-sec-0003">Search methods</h3> <p>We searched CENTRAL (which contains the Cochrane Eyes and Vision Group Trials Register) (2013, Issue 12), Ovid MEDLINE, Ovid MEDLINE In‐Process and Other Non‐Indexed Citations, Ovid MEDLINE Daily, Ovid OLDMEDLINE (January 1946 to January 2014), EMBASE (January 1980 to January 2014), Latin American and Caribbean Health Sciences Literature Database (LILACS) (January 1982 to January 2014), the <i>meta</i> Register of Controlled Trials (<i>m</i>RCT) (<a href="http://www.controlled-trials.com/" target="_blank">www.controlled‐trials.com</a>), ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov/" target="_blank">www.clinicaltrials.gov</a>), the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) (<a href="http://www.who.int/ictrp/search/en" target="_blank">www.who.int/ictrp/search/en</a>) and the US Food and Drugs Administration (FDA) web site (<a href="http://www.fda.gov/" target="_blank">www.fda.gov</a>). We did not use any date or language restrictions in the electronic searches for trials. We last searched the electronic databases on 24 January 2014. </p> </section> <section id="CD010453-sec-0004"> <h3 class="title" id="CD010453-sec-0004">Selection criteria</h3> <p>We planned to include only randomised controlled trials (RCTs) comparing outcomes of GCA with and without concurrent adjunctive use of low‐dose aspirin. </p> </section> <section id="CD010453-sec-0005"> <h3 class="title" id="CD010453-sec-0005">Data collection and analysis</h3> <p>Two authors independently assessed the search results for trials identified by the electronic searches. No trials met our inclusion criteria, therefore we undertook no assessment of risk of bias or meta‐analysis. </p> </section> <section id="CD010453-sec-0006"> <h3 class="title" id="CD010453-sec-0006">Main results</h3> <p>We found no RCTs that met the inclusion criteria.</p> </section> <section id="CD010453-sec-0007"> <h3 class="title" id="CD010453-sec-0007">Authors' conclusions</h3> <p>There is currently no evidence from RCTs to determine the safety and efficacy of low‐dose aspirin as an adjunctive treatment in GCA. Clinicians who are considering the use of low‐dose aspirin as an adjunctive treatment in GCA must also recognise the established haemorraghic risks associated with aspirin, especially in the context of concurrent treatment with corticosteroids. There is a clear need for effectiveness trials to guide the management of this life‐threatening condition. </p> </section> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD010453-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010453-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010453-abs-0007">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010453-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD010453-abs-0006">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD010453-abs-0005">Hrvatski</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD010453-abs-0004" lang="en"> <h3>Aspirin as an additional treatment for giant cell arteritis</h3> <p><b>Background</b> </p> <p>Giant cell arteritis (GCA) is a condition where inflammation destroys the wall of arterial blood vessels usually seen in the head. GCA affects people over the age of 50 years and is more common as people get older. Early on people feel tired and unwell; they have loss of appetite and can lose weight. Most people then develop a new headache, which can make it uncomfortable to touch their hair and scalp. Some people find chewing food uncomfortable. GCA can cause sudden blindness in one or both eyes. Other rare complications include double vision and life‐threatening aneurysms and stroke. </p> <p>Making the diagnosis can be difficult for doctors. Blood tests can help, but not everyone has signs in the blood of raised inflammation. A temporal artery biopsy is recommended. If the biopsy is negative some people still remain on treatment as their clinical story matches the typical disease presentation. </p> <p>At diagnosis the emergency treatment is with high‐dose steroids (corticosteroids). Corticosteroids are typically reduced slowly over 12 to 18 months, however some people relapse and need long‐term treatment. Corticosteroids have serious side effects such as weight gain, mood changes, stomach bleeds, bone thinning and fractures. Despite best treatment people can still go blind in one or both eyes. A different drug needs to be found to treat this condition to reduce the risk of blindness, other complications and treatment‐related side effects. Aspirin has been shown to have beneficial effects on the type of inflammation that causes damage in GCA and could therefore help to reduce disease‐related complications. </p> <p><b>Review question</b> </p> <p>The review authors searched the medical evidence for low‐dose aspirin used as an additional treatment to corticosteroids in GCA. The purpose was to investigate whether aspirin helps reduce the risk of blindness and other life‐threatening complications. We also wanted to know whether aspirin causes an increase in side effects, particularly stomach bleeds, when used together with corticosteroids. </p> <p><b>Key results</b> </p> <p>The evidence provided by this review is current to January 2014. There were no randomised controlled trials found that met the criteria for inclusion. There is limited medical information on the use of aspirin in GCA. </p> <p><b>Conclusions</b> </p> <p>At the present time there is not enough data to make a comment on whether aspirin is of benefit in GCA. More research is needed. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD010453-sec-0083" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD010453-sec-0083"></div> <h3 class="title" id="CD010453-sec-0084">Implications for practice</h3> <section id="CD010453-sec-0084"> <p>There is insufficient evidence to determine the safety and efficacy of aspirin as an adjunctive treatment in giant cell arteritis (GCA). Indirect support for its usage may be provided by its known antiplatelet and anti‐inflammatory effects, the presence of thrombocytosis in GCA, the beneficial effect of high‐dose aspirin in laboratory studies, the established benefit of aspirin in atherosclerotic disease and from two retrospective studies that appear to show a beneficial effect. Clinicians must recognise, however, that despite its widespread use, none of these studies provide sufficient evidence to confirm benefit in people with GCA. </p> <p>Clinicians who are considering the usage of aspirin as an adjunctive treatment in GCA must also recognise the established risks associated with aspirin, especially in the context of corticosteroid treatment. In this context there is a need to not only define whether there is a benefit to the use of aspirin in GCA, but also the size of any such benefit. Until then, in contrast to the situation with aspirin usage for the prevention or treatment of atherosclerotic disease, it will not be possible for the clinician or the patient to reliably estimate the relative benefit against harm in GCA. </p> </section> <h3 class="title" id="CD010453-sec-0085">Implications for research</h3> <section id="CD010453-sec-0085"> <p>This review demonstrates the lack of well‐designed randomised controlled trials (RCTs) to support the use of low‐dose aspirin in GCA, and highlights the need for such large‐scale effectiveness trials to guide the management of this life‐threatening condition. Such studies need to be powered both to assess the direction (i.e. benefit or harm) and size of any effect to enable appropriate clinical decisions to be made. Additionally, the outcome measures should include the major life‐ or sight‐threatening complications of both GCA and of the treatment(s) and be conducted over a sufficient time‐scale to ensure that both early and late effects are captured. </p> </section> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD010453-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD010453-sec-0022"></div> <section id="CD010453-sec-0023"> <h3 class="title" id="CD010453-sec-0023">Description of the condition</h3> <p>Giant cell arteritis (GCA), also known as temporal arteritis, is an immune‐mediated disease where inflammation affects medium to large arteries such as the extracranial branches of the carotid artery, the aorta, the coronary arteries and the renal arteries. People with GCA can complain of a variety of problems, and sometimes complain of no problems prior to blindness occurring. Despite corticosteroid treatment, GCA causes significant complications, including permanent visual loss (<a href="./references#CD010453-bbs2-0045" title="SalvaraniC , CiminoL , MacchioniP , ConsonniD , CantiniF , BajocchiG , et al. Risk factors for visual loss in an Italian population‐based cohort of patients with giant cell arteritis. Arthritis and Rheumatism2005;53(2):293‐7. ">Salvarani 2005</a>), dissecting aneurysm (<a href="./references#CD010453-bbs2-0018" title="EvansJM , O'FallonWM , HunderGG . Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis. A population‐based study. Annals of Internal Medicine1995;122(7):502‐7. ">Evans 1995</a>; <a href="./references#CD010453-bbs2-0043" title="RobsonJC , KiranA , MaskellJ , HutchingsA , ArdenN , DasguptaB , et al. The relative risk of aortic aneurysm in patients with giant cell arteritis compared with the general population of the UK. Annals of the Rheumatic Diseases 2013 Oct 4 [Epub ahead of print]. ">Robson 2013</a>) and stroke (<a href="./references#CD010453-bbs2-0008" title="NesherG , BerkunY , MatesM , BarasM , RubinowA , SonnenblickM . Low‐dose aspirin and prevention of cranial ischemic complications in giant cell arteritis. Arthritis and Rheumatism2004;50(4):1332‐7. ">Nesher 2004a</a>). GCA is associated with increased mortality (<a href="./references#CD010453-bbs2-0040" title="NordborgE , BengtssonBA . Death rates and causes of death in 284 consecutive patients with giant cell arteritis confirmed by biopsy. BMJ1989;299(6698):549‐50. ">Nordborg 1989</a>) and a reduced five‐year survival rate following diagnosis (<a href="./references#CD010453-bbs2-0014" title="CrowRW , KatzBJ , WarnerJE , AlderSC , ZhangK , SchulmanS , et al. Giant cell arteritis and mortality. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences2009;64(3):365‐9. ">Crow 2009</a>). The underlying cause of GCA is unknown. </p> <section id="CD010453-sec-0024"> <h4 class="title">Epidemiology</h4> <p>GCA is more common in white persons older than 50 years (<a href="./references#CD010453-bbs2-0030" title="LawrenceRC , HelmickCG , ArnettFC , DeyoRA , FelsonDT , GianniniEH , et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis and Rheumatism1998;41(5):778‐99. ">Lawrence 1998</a>) and the incidence increases with age (<a href="./references#CD010453-bbs2-0032" title="MachadoEB , MichetCJ , BallardDJ , HunderGG , BeardCM , ChuCP , et al. Trends in incidence and clinical presentation of temporal arteritis in Olmsted County, Minnesota, 1950‐85. Arthritis and Rheumatism1988;31(6):745‐9. ">Machado 1988</a>). The incidence of GCA in the population varies worldwide, with the highest frequencies being reported from Scandinavian countries (<a href="./references#CD010453-bbs2-0041" title="PetursdottirV , JohanssonH , NordborgE , NordborgC . The epidemiology of biopsy‐positive giant cell arteritis: special reference to cyclic fluctuations. Rheumatology1999;38(12):1208‐12. ">Petursdottir 1999</a>) and those with populations of Scandinavian descent (<a href="./references#CD010453-bbs2-0011" title="BorchersAT , GershwinME . Giant cell arteritis: a review of classification, pathophysiology, geoepidemiology and treatment. Autoimmune Reviews2012;11(6‐7):A544‐54. ">Borchers 2012</a>). There is confirmation of a genetic susceptibility for GCA (<a href="./references#CD010453-bbs2-0012" title="CarmonaFD , González‐GayMA , MartínJ . Genetic component of giant cell arteritis. Rheumatology2014;53(1):6‐18. ">Carmona 2013</a>; <a href="./references#CD010453-bbs2-0049" title="SerranoA , MárquezA , MackieSL , CarmonaFD , SolansR , Miranda‐FilloyJA , et al. Identification of the PTPN22 functional variant R620W as susceptibility genetic factor for giant cell arteritis. Annals of the Rheumatic Diseases2013;71(11):1882‐6. ">Serrano 2013</a>). </p> <p>Socio‐economic deprivation has been reported in association with ischaemic manifestations, which is not mediated by traditional cardiovascular risk factors (<a href="./references#CD010453-bbs2-0033" title="MackieSL , DasguptaB , HordonL , GoughA , GreenM , HollywoodJ , et al. Ischaemic manifestations in giant cell arteritis are associated with area level socio‐economic deprivation, but not cardiovascular risk factors. Rheumatology2011;50(11):2014‐22. ">Mackie 2011</a>). The authors concluded that this may suggest that the delay between first symptoms and presentation may play a significant role in the development of ischaemic complications. </p> </section> <section id="CD010453-sec-0025"> <h4 class="title">Presentation</h4> <p>People with GCA can typically complain of the following (<a href="./references#CD010453-bbs2-0045" title="SalvaraniC , CiminoL , MacchioniP , ConsonniD , CantiniF , BajocchiG , et al. Risk factors for visual loss in an Italian population‐based cohort of patients with giant cell arteritis. Arthritis and Rheumatism2005;53(2):293‐7. ">Salvarani 2005</a>; <a href="./references#CD010453-bbs2-0050" title="SmetanaGW , ShmerlingRH . Does this patient have temporal arteritis?. JAMA2002;287(1):92‐101. ">Smetana 2002</a>): </p> <p> <ul id="CD010453-list-0001"> <li> <p>New onset unilateral headache</p> </li> <li> <p>Scalp pain or tenderness</p> </li> <li> <p>Jaw claudication</p> </li> <li> <p>Neck pain</p> </li> <li> <p>Visual complaints such as transient visual obscurations, visual loss or double vision</p> </li> <li> <p>Constitutional symptoms such as weight loss, loss of appetite, fatigue, fever and myalgia (muscle pain) </p> </li> </ul> </p> <p>There is a dramatic variability in how people present with GCA, which makes it difficult for medical practitioners to diagnose (or dismiss) the disease on clinical grounds alone. It requires that the physician have a high index of suspicion. In one study, over 20% of patients with visual loss from biopsy‐proven GCA presented with no systemic signs (<a href="./references#CD010453-bbs2-0021" title="HayrehSS , PodhajskyPA , ZimmermanB . Occult giant cell arteritis: ocular manifestations. American Journal of Ophthalmology1998;125(4):521‐6. ">Hayreh 1998</a>). In the literature, polymyalgia rheumatica is thought by some to be closely associated with GCA, with 16% to 21% of polymyalgia rheumatica patients having GCA, and 40% to 60% of GCA patients having polymyalgia rheumatica symptoms (<a href="./references#CD010453-bbs2-0046" title="SalvaraniC , CantiniF , HunderGG . Polymyalgia rheumatica and giant‐cell arteritis. Lancet2008;372(9634):234‐45. ">Salvarani 2008</a>). For the purpose of this review polymyalgia rheumatica will not be specifically investigated. </p> </section> <section id="CD010453-sec-0026"> <h4 class="title">Diagnosis</h4> <p>Early diagnosis is paramount because there is a short window of time during which treatment can prevent serious ischaemic complications, particularly sight loss. Prior to the widespread use of corticosteroid treatment, the rate of sight loss was between 30% and 60% (<a href="./references#CD010453-bbs2-0010" title="BirkheadNC , WagenerHP , ShickRM . Treatment of temporal arteritis with adrenal corticosteroids: Results in 55 cases in which the lesion was proved at biopsy. Journal of the American Medical Association1957;163:821. ">Birkhead 1957</a>); this has been reduced to between 5% and 20% (<a href="./references#CD010453-bbs2-0045" title="SalvaraniC , CiminoL , MacchioniP , ConsonniD , CantiniF , BajocchiG , et al. Risk factors for visual loss in an Italian population‐based cohort of patients with giant cell arteritis. Arthritis and Rheumatism2005;53(2):293‐7. ">Salvarani 2005</a>). </p> <p>The clinical history and examination, including palpation of the temporal arteries, are key steps in establishing the diagnosis. Blood investigations typically include the erythrocyte sedimentation rate (ESR), C‐reactive protein (CRP) and platelet count. All three tests have a positive correlation with a diagnosis of GCA, but are frequently discordant in individual patients, leading to diagnostic uncertainty. </p> <p>Temporal artery biopsy (TAB) is the current standard diagnostic investigation for GCA. However a TAB is invasive and when unilateral has a calculated sensitivity of 87.1% (<a href="./references#CD010453-bbs2-0039" title="NiederkohrRD , LevinLA . A Bayesian analysis of the true sensitivity of a temporal artery biopsy. Investigative Ophthalmology and Visual Science2007;48(2):675‐80. ">Niederkohr 2007</a>). False negative biopsies occur due to areas of unaffected artery, so called 'skip lesions', sampling errors including sampling of a non‐involved vessel, and differences in how the biopsy is histopathologically assessed (<a href="./references#CD010453-bbs2-0034" title="MahrA , SabaM , KambouchnerM , PolivkaM , BaudrimontM , BrochériouI , et al. Temporal artery biopsy for diagnosing giant cell arteritis: the longer, the better?. Annals of the Rheumatic Diseases2006;65(6):826‐8. ">Mahr 2006</a>). These all contribute to a reduced sensitivity. Rare clinical scenarios exist in which the clinical presentation and blood testing make the diagnosis of GCA likely without the need for a TAB. However, empiric steroid therapy (treating without histological confirmation of GCA) is almost never recommended (<a href="./references#CD010453-bbs2-0038" title="NiederkohrRD , LevinLA . Management of the patient with suspected temporal arteritis: a decision‐analytic approach. Ophthalmology2005;112(5):744‐56. ">Niederkohr 2005</a>). Non‐invasive imaging modalities, such as temporal artery colour doppler ultrasound, 3‐Tesla magnetic resonance angiography and F<sup>18</sup>‐deoxyglucose positron emission tomography, are being investigated and have in some cases been adopted. However, none of these tests has been proven to be as reliable, available and cost‐effective as TAB. </p> </section> <section id="CD010453-sec-0027"> <h4 class="title">Management</h4> <p>Early intervention with high‐dose corticosteroids is the standard treatment for GCA. Subsequently corticosteroids are tapered according to clinical symptoms, signs and acute‐phase serological markers (ESR and CRP). Typically treatment is required for a prolonged period of time. A randomised controlled trial found that the total cumulative steroid dose was reduced by initiating treatment with three days of pulsed intravenous methylprednisolone (<a href="./references#CD010453-bbs2-0036" title="MazlumzadehM , HunderGG , EasleyKA , CalamiaKT , MattesonEL , GriffingWL , et al. Treatment of giant cell arteritis using induction therapy with high‐dose glucocorticoids: a double‐blind, placebo‐controlled, randomized prospective clinical trial. Arthritis and Rheumatism2006;54(10):3310‐8. ">Mazlumzadeh 2006</a>). </p> <p>Relapse can occur, whether clinical or biochemical. Once treatment is initiated, the risk of recurrent visual loss is as high as 7% at three years (<a href="./references#CD010453-bbs2-0013" title="ChanCC , PaineM , O'DayJ . Predictors of recurrent ischemic optic neuropathy in giant cell arteritis. Journal of Neuro‐Ophthalmology2005;25(1):14‐7. ">Chan 2005</a>). In those who discontinue corticosteroid therapy within 12 months, the rate of relapse is as high as 77% (<a href="./references#CD010453-bbs2-0026" title="HoffmanGS , CidMC , HellmannDB , GuillevinL , StoneJH , SchousboeJ , et al. A multicenter, randomized, double blind placebo controlled trial of adjuvant methotrexate treatment for giant cell arteritis. Arthritis and Rheumatism2002;46(5):1309‐18. ">Hoffman 2002</a>). Late recurrences have also been reported (<a href="./references#CD010453-bbs2-0029" title="KimN , TrobeJD , FlintA , KeoleianG . Late ipsilateral recurrence of ischemic optic neuropathy in giant cell arteritis. Journal of Neuro‐Ophthalmology2003;23(2):122‐6. ">Kim 2003</a>). Corticosteroid toxicity remains a concern, especially as it is pronounced in the older age group most affected by GCA. In routine practice gastric and bone prophylaxis are given concurrently. The British Society of Rheumatology Guidelines also recommend the use of low‐dose aspirin (<a href="./references#CD010453-bbs2-0015" title="DasguptaB , BorgFA , HassanN , AlexanderL , BarracloughK , BourkeB , et al. BSR and BHPR guidelines for the management of giant cell arteritis. Rheumatology2010;49(8):1594‐7. ">Dasgupta 2010</a>). </p> <p>Combined therapy with other immunosuppressant drugs is being evaluated: azathioprine has not proven to be effective (<a href="./references#CD010453-bbs2-0016" title="DeSilvaM , HazlemanBL . Azathioprine in giant cell arteritis/polymyalgia rheumatica: a double‐blind study. Annals of the Rheumatic Diseases1986;45(2):136‐8. ">De Silva 1986</a>). A meta‐analysis of the adjunctive use of methotrexate reported a significantly reduced risk of primary and secondary relapse, with hazard ratios of 0.65 (95% confidence interval (CI) 0.44 to 0.98, P value = 0.04) and 0.49 (95% CI 0.27 to 0.89, P value = 0.02), respectively. There was a reduction in the cumulative corticosteroid dose at 12 weeks (P value = 0.01), 24 weeks (P value = 0.01), 36 weeks (P value &lt; 0.001) and 48 weeks (P value &lt; 0.001). There was no difference in the corticosteroid‐related side effects between the treatment groups (<a href="./references#CD010453-bbs2-0035" title="MahrAD , JoverJA , SpieraRF , Hernández‐GarcíaC , Fernández‐GutiérrezB , LavalleyMP , et al. Adjunctive methotrexate for treatment of giant cell arteritis: an individual patient data meta‐analysis. Arthritis and Rheumatism2007;56(8):2789‐97. ">Mahr 2007</a>). Biological agents such as tumour necrosis factor‐α inhibitors have been investigated and have not proven to be of benefit (<a href="./references#CD010453-bbs2-0027" title="HoffmanGS , CidMC , Rendt‐ZagarKE , MerkelPA , WeyandCM , StoneJH , et al. Infliximab for maintenance of glucocorticosteroid‐induced remission of giant cell arteritis: a randomized trial. Annals of Internal Medicine2007;146(9):621‐30. ">Hoffman 2007</a>); the interleukin (IL)‐6 receptor antagonist tocilizumab is currently under trial (<a href="./references#CD010453-bbs2-0051" title="UnizonySH , DasguptaB , FishelevaE , RowellL , SchettG , SpieraR , et al. Design of the tocilizumab in giant cell arteritis trial. International Journal of Rheumatology 2013 Apr 7 [Epub ahead of print]. ">Unizony 2013</a>). The role of second‐line steroid‐sparing agents is currently being evaluated by another Cochrane review (<a href="./references#CD010453-bbs2-0025" title="HillCL , ColeA , LesterS , WhittleSL . Steroid sparing drug treatments for giant cell arteritis. Cochrane Database of Systematic Reviews2009, Issue 1. [DOI: 10.1002/14651858.CD005323.pub2] ">Hill 2009</a>), and is therefore beyond the remit of this review. </p> </section> </section> <section id="CD010453-sec-0028"> <h3 class="title" id="CD010453-sec-0028">Description of the intervention</h3> <p>Antiplatelet treatments are drugs that interfere with platelet function: they inhibit thrombosis (clot) formation by decreasing platelet aggregation. Platelet aggregation is a dynamic and complex process where platelets stick to each other at the site of blood vessel injury to form a clot. Aspirin (acetylsalicylic acid; ASA) is an oral antiplatelet drug, which is technically termed a cyclooxygenase (COX) inhibitor. Aspirin irreversibly inhibits the enzyme COX, resulting in reduced platelet production of thromboxane. Low‐dose aspirin is well known to reduce the risk of stroke in other populations (<a href="./references#CD010453-bbs2-0005" title="LeeMS , SmithSD , GalorA , HoffmanGS . Antiplatelet and anticoagulant therapy in patients with giant cell arteritis. Arthritis and Rheumatism2006;54(10):3306‐9. ">Lee 2006</a>; <a href="./references#CD010453-bbs2-0052" title="WeismanSM , GrahamDY . Evaluation of the benefits and risks of low‐dose aspirin in the secondary prevention of cardiovascular and cerebrovascular events. Archives of Internal Medicine2002;162(19):2197‐202. ">Weisman 2002</a>). </p> </section> <section id="CD010453-sec-0029"> <h3 class="title" id="CD010453-sec-0029">How the intervention might work</h3> <section id="CD010453-sec-0030"> <h4 class="title">Description of the immunopathogenesis of GCA</h4> <p>GCA is an immune‐mediated primary systemic vasculitis, where the arterial wall is the site of the disease process. Activated immune cells, macrophages and T‐cells in the adventitia (arterial wall) produce high levels of cytokines, such as interferon‐γ (IFN‐γ), interleukin‐2 (IL‐2) and interleukin‐17 (IL‐17). These stimulate macrophages in the media to express metalloproteinases and reactive oxygen species, which break down the internal elastic laminae. A healing response causes proliferation of smooth muscle cells and intimal hyperplasia, which results in vascular stenosis and occlusion (<a href="./references#CD010453-bbs2-0031" title="LyKH , RégentA , TambyMC , MouthonL . Pathogenesis of giant cell arteritis: More than just an inflammatory condition?. Autoimmune Reviews2010;9(10):635‐45. ">Ly 2010</a>; <a href="./references#CD010453-bbs2-0054" title="WeyandCM , Ma‐KrupaW , GoronzyJJ . Immunopathways in giant cell arteritis and polymyalgia rheumatica. Autoimmune Reviews2004;3(1):46‐53. ">Weyand 2004</a>; <a href="./references#CD010453-bbs2-0055" title="WeyandCM , YoungeBR , GoronzyJJ . IFN‐γ and IL‐17: the two faces of T‐cell pathology in giant cell arteritis. Current Opinion in Rheumatology2011;23(1):43‐9. ">Weyand 2011</a>). </p> </section> <section id="CD010453-sec-0031"> <h4 class="title">Altering inflammation</h4> <p>Aspirin has been shown to have a wide range of effects on the immune system, including inducing tolerance in dendritic cells and inducing regulatory T cells (<a href="./references#CD010453-bbs2-0028" title="HussainM , JaveedA , AshrafM , ZhaoY , MukhtarMM , RehmanMU . Aspirin and immune system. International Immunopharmacology2012;12(1):10‐20. ">Hussain 2011</a>). In addition, aspirin suppresses the transcription of IFN‐γ, a key cytokine in GCA that recruits macrophages in the vessel to produce metalloproteinases and reactive oxygen species that cause destruction of the internal laminae (<a href="./references#CD010453-bbs2-0053" title="WeyandCM , KaiserM , YangH , YoungeB , GoronzyJJ . Therapeutic effects of acetylsalicylic acid in giant cell arteritis. Arthritis and Rheumatism2002;46(2):457‐66. ">Weyand 2002</a>). Corticosteroids suppress the production of macrophage‐derived IL‐1, IL‐6 and NOS‐2 and suppress the T cell cytokine IL‐2. They only have a marginal effect on IFN‐γ. Therefore the mechanism of action of aspirin would be complementary to corticosteroids. </p> </section> <section id="CD010453-sec-0032"> <h4 class="title">Preventing thrombosis formation</h4> <p>Aspirin has an antithrombotic action via its inhibition of thromboxane A2 production and consequent reduction in platelet aggregation. Although there is no clear evidence that the reactive thrombocytosis associated with GCA can cause thrombosis, thrombus formation has been histologically documented in the vertebral arteries of a small case series of GCA patients (<a href="./references#CD010453-bbs2-0044" title="RüeggS , EngelterS , JeanneretC , HetzelA , ProbstA , SteckAJ , et al. Bilateral vertebral artery occlusion resulting from giant cell arteritis: report of 3 cases and review of the literature. Medicine2003;82(1):1‐12. ">Rüegg 2003</a>). </p> </section> </section> <section id="CD010453-sec-0033"> <h3 class="title" id="CD010453-sec-0033">Why it is important to do this review</h3> <p>To assess the safety and effectiveness of using low‐dose aspirin as an adjunctive treatment, in combination with corticosteroids, for treatment of GCA. GCA is associated with significant organ and life‐threatening complications such as: </p> <p> <ul id="CD010453-list-0002"> <li> <p>sight loss (<a href="./references#CD010453-bbs2-0045" title="SalvaraniC , CiminoL , MacchioniP , ConsonniD , CantiniF , BajocchiG , et al. Risk factors for visual loss in an Italian population‐based cohort of patients with giant cell arteritis. Arthritis and Rheumatism2005;53(2):293‐7. ">Salvarani 2005</a>); </p> </li> <li> <p>thoracic aortic aneurysms (<a href="./references#CD010453-bbs2-0018" title="EvansJM , O'FallonWM , HunderGG . Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis. A population‐based study. Annals of Internal Medicine1995;122(7):502‐7. ">Evans 1995</a>); </p> </li> <li> <p>abdominal aortic aneurysms (<a href="./references#CD010453-bbs2-0018" title="EvansJM , O'FallonWM , HunderGG . Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis. A population‐based study. Annals of Internal Medicine1995;122(7):502‐7. ">Evans 1995</a>); and </p> </li> <li> <p>stroke (<a href="./references#CD010453-bbs2-0008" title="NesherG , BerkunY , MatesM , BarasM , RubinowA , SonnenblickM . Low‐dose aspirin and prevention of cranial ischemic complications in giant cell arteritis. Arthritis and Rheumatism2004;50(4):1332‐7. ">Nesher 2004a</a>; <a href="./references#CD010453-bbs2-0037" title="NesherG , BerkunY , MatesM , BarasM , NesherR , RubinowA , et al. Risk factors for cranial ischemic complications in giant cell arteritis. Medicine2004;83(2):114‐22. ">Nesher 2004b</a>). </p> </li> </ul> </p> <p>It is clear that although corticosteroids are the main therapeutic intervention for GCA, adjunctive therapy is required because: </p> <p> <ol id="CD010453-list-0003"> <li> <p>the spectrum of corticosteroid repression of the inflammatory cytokines found in GCA is inadequate; </p> </li> <li> <p>despite adequate treatment with corticosteroids, there is histopathological evidence that the inflammatory infiltration of the vessel wall persists; </p> </li> <li> <p>late complications, such as thoracic and abdominal aorta aneurysm, occur; and</p> </li> <li> <p>corticosteroids do not shorten the natural history of the disease.</p> </li> </ol> </p> <p>There is controversy in the literature over whether antiplatelet therapy should be considered in GCA (<a href="./references#CD010453-bbs2-0022" title="HayrehSS , ZimmermanB . Management of giant cell arteritis. Our 27‐year clinical study: new light on old controversies. Ophthalmologica2003;217(4):239‐59. ">Hayreh 2003</a>; <a href="./references#CD010453-bbs2-0023" title="HellmannDB . Low dose aspirin in the treatment of giant cell arteritis. Arthritis and Rheumatism2004;50(4):1026‐7. ">Hellmann 2004</a>). <a href="./references#CD010453-bbs2-0022" title="HayrehSS , ZimmermanB . Management of giant cell arteritis. Our 27‐year clinical study: new light on old controversies. Ophthalmologica2003;217(4):239‐59. ">Hayreh 2003</a> points out that although essential thrombocytosis has increased thrombotic morbidity, the thrombocytosis in GCA is reactive and thus an antithrombotic agent is likely to have little effect. There is some evidence suggesting that the risk of cranial ischaemic complications in GCA is reduced by aspirin (<a href="./references#CD010453-bbs2-0005" title="LeeMS , SmithSD , GalorA , HoffmanGS . Antiplatelet and anticoagulant therapy in patients with giant cell arteritis. Arthritis and Rheumatism2006;54(10):3306‐9. ">Lee 2006</a>; <a href="./references#CD010453-bbs2-0008" title="NesherG , BerkunY , MatesM , BarasM , RubinowA , SonnenblickM . Low‐dose aspirin and prevention of cranial ischemic complications in giant cell arteritis. Arthritis and Rheumatism2004;50(4):1332‐7. ">Nesher 2004a</a>). In addition, the presence of atherosclerosis risk factors at the time of diagnosis of GCA may influence the development of cranial ischaemic complications (<a href="./references#CD010453-bbs2-0020" title="Gonzalez‐GayMA , PiñeiroA , Gomez‐GigireyA , Garcia‐PorruaC , Pego‐ReigosaR , Dierssen‐SotosT , et al. Influence of traditional risk factors of atherosclerosis in the development of severe ischemic complications in giant cell arteritis. Medicine2004;83(6):342‐7. ">Gonzalez‐Gay 2004</a>). Thus aspirin therapy needs to be systematically evaluated. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD010453-sec-0034" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD010453-sec-0034"></div> <p>To assess the safety and effectiveness of low‐dose aspirin, as an adjunctive, in the treatment of giant cell arteritis (GCA). </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD010453-sec-0035" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD010453-sec-0035"></div> <section id="CD010453-sec-0036"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD010453-sec-0037"> <h4 class="title">Types of studies</h4> <p>We planned to include randomised controlled trials (RCTs) comparing outcomes of GCA with and without concurrent adjunctive use of low‐dose aspirin. </p> </section> <section id="CD010453-sec-0038"> <h4 class="title">Types of participants</h4> <p>For this review we planned to included studies that enrolled participants who:</p> <p> <ul id="CD010453-list-0004"> <li> <p>were over the age of 50 years; and</p> </li> <li> <p>had histological findings of GCA on temporal artery biopsy, such as the presence of inflammatory cell infiltrate, giant cells, intimal thickening and fragmentation of the internal elastic lamina. </p> </li> </ul> </p> <p>We planned to exclude studies where the participant group has GCA diagnosed by clinical criteria alone, or that included juvenile temporal arteritis. </p> </section> <section id="CD010453-sec-0039"> <h4 class="title">Types of interventions</h4> <p>We planned to include trials where low‐dose aspirin in combination with corticosteroids was compared to placebo or no aspirin. </p> </section> <section id="CD010453-sec-0040"> <h4 class="title">Types of outcome measures</h4> <p>For the purpose of the review sight loss is defined as any loss of visual acuity or development of a visual field defect in either eye that is attributable to GCA at baseline, 24 weeks and 48 weeks. </p> <section id="CD010453-sec-0041"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD010453-list-0005"> <li> <p>Risk of sight‐threatening complications at one year, with or without aspirin use, defined as continued (worsening) or recurrent (repeated) sight loss in the affected eye, or the onset of sight loss in the other previously non‐affected eye. </p> </li> <li> <p>Risk of life‐threatening ischaemic complications at one year, with or without aspirin use, which includes any one of the following: cranial nerve palsy, aneurysm, myocardial infarction, renal infarction or stroke. </p> </li> </ol> </p> </section> <section id="CD010453-sec-0042"> <h5 class="title">Secondary outcomes</h5> <section id="CD010453-sec-0043"> <h6 class="title">Disease relapse</h6> <p>Time‐to‐event outcome of biochemical and/or clinical relapse. We defined relapse as the re‐introduction of corticosteroids, or an increase of corticosteroids, to suppress either inflammatory markers (biochemical relapse) or any GCA‐related clinical symptoms (clinical relapse). </p> <p>If the included studies did not report biochemical or clinical relapse as time‐to‐event, we planned to analyse the proportion of participants in each group experiencing a biochemical or clinical relapse as defined above at one‐year follow‐up and at other time points as reported in the included studies. </p> </section> <section id="CD010453-sec-0044"> <h6 class="title">Disease remission</h6> <p>Time‐to‐event outcome of disease remission defined as participants no longer requiring immunosuppression, where inflammatory markers have normalised and there are no signs and symptoms of GCA. </p> <p>If the included studies did not report time‐to‐event data for disease remission, we planned to analyse the proportion of participants in each group with remission as defined above at one‐year follow‐up and at other time points as reported by included studies. </p> </section> <section id="CD010453-sec-0045"> <h6 class="title">Mortality</h6> <p>The proportion of patients dying in each treatment arm during the study period.</p> </section> <section id="CD010453-sec-0046"> <h6 class="title">Adverse outcomes</h6> <p>We planned to record the number of adverse events reported during the study period for each treatment arm. Treatment‐related adverse events include gastrointestinal ulcers, stomach bleeding and tinnitus. In addition, we planned to record the number of patients discontinuing with the study due to drug‐related side effects. </p> </section> <section id="CD010453-sec-0047"> <h6 class="title">Economic data</h6> <p>We planned to extract any available cost analysis.</p> </section> <section id="CD010453-sec-0048"> <h6 class="title">Quality of life data</h6> <p>We planned to collect any information on the effects on quality of life. We planned to document Information about patient preference with respect to therapy, including ease of administration, convenience, number of required follow‐up visits and out‐of‐pocket expenses after treatment initiated. </p> </section> </section> </section> </section> <section id="CD010453-sec-0049"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD010453-sec-0050"> <h4 class="title">Electronic searches</h4> <p>We searched CENTRAL (which contains the Cochrane Eyes and Vision Group Trials Register) (2013, Issue 12), Ovid MEDLINE, Ovid MEDLINE In‐Process and Other Non‐Indexed Citations, Ovid MEDLINE Daily, Ovid OLDMEDLINE (January 1946 to January 2014), EMBASE (January 1980 to January 2014), Latin American and Caribbean Health Sciences Literature Database (LILACS) (January 1982 to January 2014), the <i>meta</i> Register of Controlled Trials (<i>m</i>RCT) (<a href="http://www.controlled-trials.com/" target="_blank">www.controlled‐trials.com</a>), ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov/" target="_blank">www.clinicaltrials.gov</a>), the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) (<a href="http://www.who.int/ictrp/search/en" target="_blank">www.who.int/ictrp/search/en</a>) and the US Food and Drugs Administration (FDA) web site (<a href="http://www.fda.gov/" target="_blank">www.fda.gov</a>). We did not use any date or language restrictions in the electronic searches for trials. We last searched the electronic databases on 24 January 2014. </p> <p>See: Appendices for details of search strategies for CENTRAL (<a href="./appendices#CD010453-sec-0088">Appendix 1</a>), MEDLINE (<a href="./appendices#CD010453-sec-0089">Appendix 2</a>), EMBASE (<a href="./appendices#CD010453-sec-0090">Appendix 3</a>), LILACS (<a href="./appendices#CD010453-sec-0091">Appendix 4</a>), <i>m</i>RCT (<a href="./appendices#CD010453-sec-0092">Appendix 5</a>), ClinicalTrials.gov (<a href="./appendices#CD010453-sec-0093">Appendix 6</a>), the ICTRP (<a href="./appendices#CD010453-sec-0094">Appendix 7</a>) and the FDA web site (<a href="./appendices#CD010453-sec-0095">Appendix 8</a>). </p> </section> <section id="CD010453-sec-0051"> <h4 class="title">Searching other resources</h4> <p>We searched the bibliographies of retrieved articles for additional references. In addition, we contacted experts within the field where appropriate. </p> </section> </section> <section id="CD010453-sec-0052"> <h3 class="title" id="CD010453-sec-0052">Data collection and analysis</h3> <section id="CD010453-sec-0053"> <h4 class="title">Selection of studies</h4> <p>Two review authors (SPM and NS) independently screened the titles and abstracts identified from the above searches. We obtained a full‐text copy for any study which appeared partially or definitely relevant from this initial assessment and which met the inclusion criteria. </p> <p>Two review authors (SPM and NS) examined the full‐text articles independently. If any clarification or further details were needed to make a complete assessment of any study, we planned to contact the authors of the study directly. We planned to group studies as included, excluded or unsure. Where a disagreement arose between the two authors another review author (MAB) adjudicated. </p> <section id="CD010453-sec-0054"> <h5 class="title">Methods for future updates</h5> <p>We will use the following methods to evaluate included studies identified in future updates. </p> </section> </section> <section id="CD010453-sec-0055"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (SPM and NS) will use an electronic data extraction form to independently extract all data required for the review in relation to study characteristics, primary and secondary outcomes. One review author (SPM) will enter the data into Review Manager (<a href="./references#CD010453-bbs2-0042" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012. ">RevMan 2012</a>) and a second review author (NS) will verify all entries. We will record the following: </p> <p> <ul id="CD010453-list-0006"> <li> <p>Methods: study design, allocation, masking, exclusions (especially those after randomisation), patient drop‐out and loss to follow‐up and noncompliance. </p> </li> <li> <p>Participants: country and setting where participants enrolled, number of patients in study, number of patients randomised (if applicable), age, age range, sex, number of women and number of men, ethnic group, inclusion criteria and exclusion criteria. </p> </li> <li> <p>Interventions: treatment, control, duration of treatment, dose of treatment.</p> </li> <li> <p>Outcomes: endpoints on which data will be collected, length of follow‐up, number of relapses and ischaemic complications, and time to disease relapse and remission, source of funding and declaration of interest. </p> </li> </ul> </p> <section id="CD010453-sec-0056"> <h5 class="title">'Summary of findings' table</h5> <p>We will construct 'Summary of findings' tables incorporating the body of evidence included in this review, focusing on patients with biopsy‐confirmed GCA on standard treatment. We will include the following outcomes in each 'Summary of findings' table: 1) sight‐threatening ischaemic events; 2) life‐threatening ischaemic events; 3) disease relapse; 4) disease remission; and 5) mortality. For each outcome, we will use the results from included studies to estimate the absolute risks for the aspirin and comparison groups as well as the relative effect estimates (risk ratio). </p> <p>We will use the GRADE (Grading of Recommendation Assessment Development and Evaluation) approach as described in Chapter 12 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> to rate the overall quality of the body of evidence for the five outcomes listed above according to each comparison (<a href="./references#CD010453-bbs2-0048" title="SchünemannHJ , OxmanAD , VistGE , HigginsJPT , DeeksJJ , GlasziouP , et al. Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0. (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Schünemann 2011</a>). Two review authors will evaluate the evidence for the following factors that may decrease the quality of evidence: 1) factors related to design and execution of included studies (risk of bias); 2) indirectness in the population, intervention, control, outcomes; 3) inconsistency or heterogeneity in reported results; 4) imprecision in effect estimates influenced by sample size and confidence intervals; and 5) potential publication bias. If there are insufficient quantitative results, we will provide a narrative 'Summary of findings' table addressing the impact of the intervention on the same outcomes described previously. </p> </section> </section> <section id="CD010453-sec-0057"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>We will critically appraise all studies meeting our inclusion criteria in relation to internal study validity with emphasis on selection bias, performance bias, attrition bias and reporting bias. Two review authors (SPM and NS) will assess the risk of bias using the Cochrane 'Risk of bias' tool given in Chapter 8 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD010453-bbs2-0024" title="HigginsJPT , AltmanDG , Sterne JAC(editors) . Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). We will make the following judgements for each domain: 'high', 'low', or 'unclear' risk of bias. If a consensus cannot be reached for the final judgement, a third review author (MAB) will adjudicate. Each 'Risk of bias' domain will address the following methodological study characteristics:                                         </p> <section id="CD010453-sec-0058"> <h5 class="title">Selection bias</h5> <p> <ul id="CD010453-list-0007"> <li> <p>Random sequence generation</p> </li> <li> <p>Allocation concealment</p> </li> </ul> </p> </section> <section id="CD010453-sec-0059"> <h5 class="title">Performance and detection bias</h5> <p> <ul id="CD010453-list-0008"> <li> <p>Masking of study participants to their assigned treatment</p> </li> <li> <p>Masking of study personnel providing care to the study participants</p> </li> <li> <p>Masking of study personnel assessing treatment outcomes</p> </li> </ul> </p> </section> <section id="CD010453-sec-0060"> <h5 class="title">Attrition bias</h5> <p> <ul id="CD010453-list-0009"> <li> <p>Incomplete outcome data</p> </li> </ul> </p> </section> <section id="CD010453-sec-0061"> <h5 class="title">Reporting bias</h5> <p> <ul id="CD010453-list-0010"> <li> <p>Selective outcome reporting</p> </li> </ul> </p> </section> </section> <section id="CD010453-sec-0062"> <h4 class="title">Measures of treatment effect</h4> <p>For the primary outcomes, ischaemic complications (sight‐threatening and life‐threatening), and the secondary outcomes, relapse (biochemical and clinical) and disease remission, we will plan to use risk ratios and corresponding variance estimates such as 95% confidence intervals to measure the treatment effect. If the included studies do not measure treatment effects as time‐to‐event outcomes, we will record the proportion of participants in each treatment arm that experience an ischaemic complication, relapse or disease remission at the end of one year of follow‐up and compute risk ratio estimates for each outcome. We will also record the number of deaths for each treatment arm and compute risk ratio estimates for mortality. </p> </section> <section id="CD010453-sec-0063"> <h4 class="title">Unit of analysis issues</h4> <p>The unit of analysis will be the individual participant. There may be variation in which RCTs record visual outcomes in terms of reporting as unilateral or bilateral. </p> </section> <section id="CD010453-sec-0064"> <h4 class="title">Dealing with missing data</h4> <p>We will study intention‐to‐treat to assess the number of patients who were assigned to treatment and the number of patients who were actually treated. We will report follow‐up by treatment group and collect data on reason for loss to follow‐up, where possible. We will contact study authors for missing outcome data and allow four weeks for investigator responses. If study investigators do not respond or cannot provide the data that is required we will record this as a potential source of attrition bias, as per the Cochrane 'Risk of bias' reporting tool. </p> </section> <section id="CD010453-sec-0065"> <h4 class="title">Assessment of heterogeneity</h4> <p>We will evaluate clinical heterogeneity (participants, interventions and outcomes reported) and methodological heterogeneity (study design and risk of bias) across the included studies before conducting a meta‐analysis. We will also examine the size and direction of effect estimates and overlap of 95% confidence intervals. We will use the I² statistic to quantify inconsistency across studies, with a value of 50% or more indicating significant statistical heterogeneity. </p> </section> <section id="CD010453-sec-0066"> <h4 class="title">Assessment of reporting biases</h4> <p>We will construct and inspect a funnel plot of the available studies for asymmetry to ascertain publication bias. However, if the number of studies is low (fewer than 10), or the sample sizes within the studies are small, this could be unreliable. Asymmetry within the plot may also be due to language and citation bias or poor methodological design of the trial. </p> </section> <section id="CD010453-sec-0067"> <h4 class="title">Data synthesis</h4> <p>When three or more studies are included in a meta‐analysis, or when noticeable clinical or methodological heterogeneity is detected, we will use a random‐effects model. We will use fixed‐effect models when fewer than three studies are included in a meta‐analysis. We will use the generic inverse variance method in Review Manager 5 to perform meta‐analyses of time‐to‐event outcomes (relapse and disease remission). For dichotomous data (e.g. ischaemic complications and number of deaths per treatment group) we will calculate Mantel‐Haenszel risk ratios with 95% confidence intervals as outlined in Chapter 9 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD010453-bbs2-0017" title="DeeksJJ , HigginsJPT , Altman DG(editors) . Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Deeks 2011</a>). </p> </section> <section id="CD010453-sec-0068"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>If multiple interventions are reported, such as high‐dose and low‐dose aspirin, we will perform separate subgroup analyses according to specific treatment regimens. </p> </section> <section id="CD010453-sec-0069"> <h4 class="title">Sensitivity analysis</h4> <p>We will perform sensitivity analyses to determine the impact on the treatment effects of removing studies judged to have a high risk of bias for incomplete outcome data and selective outcome reporting, industry‐funded studies and unpublished studies (conference abstracts). </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD010453-sec-0070" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD010453-sec-0070"></div> <section id="CD010453-sec-0071"> <h3 class="title">Description of studies</h3> <section id="CD010453-sec-0072"> <h4 class="title">Results of the search</h4> <p>The electronic searches yielded a total of 174 records (<a href="#CD010453-fig-0001">Figure 1</a>). After deduplication we screened 157 records and excluded 148 records as not being relevant to the review question. We obtained full‐text copies of nine reports for further assessment, however we did not identify any potentially eligible studies for this review. </p> <div class="figure" id="CD010453-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Results from searching for studies for inclusion in the review" data-id="CD010453-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010453.pub2/media/CDSR/CD010453/image_n/nCD010453-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Results from searching for studies for inclusion in the review</p> </div> </div> </div> </section> <section id="CD010453-sec-0073"> <h4 class="title">Included studies</h4> <p>No studies were included.</p> </section> <section id="CD010453-sec-0074"> <h4 class="title">Excluded studies</h4> <p>We reviewed nine full‐text articles: seven were retrospective studies, one was a case report and one an editorial. None met the inclusion criteria. </p> </section> </section> <section id="CD010453-sec-0075"> <h3 class="title">Risk of bias in included studies</h3> <p>We did not complete 'Risk of bias' assessment as no studies were included in the review.</p> </section> <section id="CD010453-sec-0076"> <h3 class="title" id="CD010453-sec-0076">Effects of interventions</h3> <p>We did not complete an assessment of the effects of the intervention as no studies were included in the review. </p> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD010453-sec-0077" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD010453-sec-0077"></div> <p>We found no randomised controlled trials (RCTs) that investigated the adjuvant use of aspirin therapy for giant cell arteritis (GCA). Since no RCTs were found, we have described the other relevant studies identified in the searches in order to comment on the current evidence base for clinical practice (<a href="#CD010453-tbl-0001">Table 1</a>). </p> <div class="table" id="CD010453-tbl-0001"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Summary of current medical evidence reporting on aspirin use in GCA</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Article</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of participants with GCA</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Methods</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>GCA</b> </p> <p><b>Biopsy‐proven (%)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number on ASA at time of diagnosis</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number started on ASA after diagnosis</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Comment on adjunctive therapy</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Conclusion</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Berger 2009</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>85</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective case series</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>78%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22 participants took ASA treatment prior to GCA diagnosis</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No benefit of established use of ASA on rate of ischaemic complications</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Chuang 1982</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective case series of PMR and GCA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lee 2006</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>143</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective case series</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>73%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ASA not reported separately</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ASA not reported separately</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60.1% received long‐term antiplatelet or anticoagulation</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16.2% versus 48% had ischaemic complication (P value &lt; 0.0005) in favour of antiplatelet/coagulation</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Liozon 2001</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>174</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prospective observational case series investigating permanent visual loss</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>84.5%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low molecular weight heparin and intravenous heparin were used for visual loss</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Thrombocytosis was strongly associated with risk of permanent visual loss</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Narvaez 2008</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>121</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>73%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30.5% were on ASA and 7% on another antiplatelet agent prior to symptoms/signs of GCA </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No observed benefit of antiplatelet therapy on the incidence of ischaemic complications or disease outcome </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nesher 2004a</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>175</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>87%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>36</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>41</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21% were already using low‐dose ASA at time of GCA diagnosis</p> <p>All given prednisolone at time of GCA diagnosis</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>At diagnosis 8% with ASA had ischaemic complications compared to 29% who did not have ASA (P value = 0.01) </p> <p>At 3 months 3% with ASA had ischaemic complications compared to 13% who did not have ASA (P value = 0.02) </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Souza 2013</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not known</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ASA not reported separately</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ASA not reported separately</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32 (71.1%) were reported on aspirin</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Aspirin was of statistical benefit in preventing relapse (P value = 0.023)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>ASA: aspirin<br/> GCA: giant cell arteritis<br/> PMR: polymyalgia rheumatica </p> </div> </div> <p>Indirect support for the use of aspirin in GCA that is commonly cited includes a number of observations. First, aspirin has well‐documented antiplatelet and anti‐inflammatory effects. Second, thrombocytosis is a characteristic finding in GCA and has been associated with ischaemic complications such as risk of visual loss (<a href="./references#CD010453-bbs2-0006" title="LiozonE , HerrmannF , LyK , RobertPY , LoustaudV , SoriaP , et al. Risk factors for visual loss in giant cell (temporal) arteritis: a prospective study of 174 patients. American Journal of Medicine2001;111(3):211‐7. ">Liozon 2001</a>). Third, chimeric mouse models of GCA suggest that very high‐dose aspirin reduces interferon gamma levels to a greater extent than corticosteroids (<a href="./references#CD010453-bbs2-0053" title="WeyandCM , KaiserM , YangH , YoungeB , GoronzyJJ . Therapeutic effects of acetylsalicylic acid in giant cell arteritis. Arthritis and Rheumatism2002;46(2):457‐66. ">Weyand 2002</a>). Fourth, aspirin has an established role in the reduction of ischaemic complications in atherosclerotic disease. Finally, three retrospective studies are cited as supporting the use of aspirin as an adjunctive therapy in GCA where they collectively analyse 136 participants who presented with established aspirin use (<a href="./references#CD010453-bbs2-0005" title="LeeMS , SmithSD , GalorA , HoffmanGS . Antiplatelet and anticoagulant therapy in patients with giant cell arteritis. Arthritis and Rheumatism2006;54(10):3306‐9. ">Lee 2006</a>; <a href="./references#CD010453-bbs2-0008" title="NesherG , BerkunY , MatesM , BarasM , RubinowA , SonnenblickM . Low‐dose aspirin and prevention of cranial ischemic complications in giant cell arteritis. Arthritis and Rheumatism2004;50(4):1332‐7. ">Nesher 2004a</a>; <a href="./references#CD010453-bbs2-0009" title="SouzaAW , OkamotoKY , AbrantesF , SchauB , BacchiegaAB , ShinjoSK . Giant cell arteritis: a multicenter observational study in Brazil. Clinics2013;68(3):317‐22. ">Souza 2013</a>). These studies, although not eligible for analysis within this review, are briefly discussed below. </p> <p><a href="./references#CD010453-bbs2-0008" title="NesherG , BerkunY , MatesM , BarasM , RubinowA , SonnenblickM . Low‐dose aspirin and prevention of cranial ischemic complications in giant cell arteritis. Arthritis and Rheumatism2004;50(4):1332‐7. ">Nesher 2004a</a> found that around 20% presented with GCA whilst already using low‐dose aspirin exclusively for secondary prevention (i.e. all had previously had a cardiovascular event). There was no difference found between the established aspirin‐treated and non‐aspirin group in terms of their characteristics of presentation with GCA. What Nesher and colleagues did find was that ischaemic complications at presentation and subsequently at three months post‐presentation in the aspirin‐treated group were significantly reduced, but not absent. As commented on by <a href="./references#CD010453-bbs2-0004" title="EspinozaLR . Clinical trials in giant cell arteritis. Current Rheumatology Reports2005;7(4):263‐4. ">Espinoza 2005</a>, this study is limited as it was retrospective with no pre‐defined treatment protocol: participants could be started on aspirin at the physician's discretion. The incidence of ischaemic complications in this study was high at 33% of those studied, 25% prior to diagnosis and 8% post‐diagnosis (<a href="./references#CD010453-bbs2-0023" title="HellmannDB . Low dose aspirin in the treatment of giant cell arteritis. Arthritis and Rheumatism2004;50(4):1026‐7. ">Hellmann 2004</a>). Other confounding issues include the participant's underlying predisposition to cardiovascular risk and the directed use of cardiovascular‐modifying medications, such as statins and antihypertensive medications. Participants in <a href="./references#CD010453-bbs2-0005" title="LeeMS , SmithSD , GalorA , HoffmanGS . Antiplatelet and anticoagulant therapy in patients with giant cell arteritis. Arthritis and Rheumatism2006;54(10):3306‐9. ">Lee 2006</a> used both antiplatelet and anticoagulation therapy and found use of either significantly reduced the risk of an ischaemic event (P value &gt; 0.0005). <a href="./references#CD010453-bbs2-0009" title="SouzaAW , OkamotoKY , AbrantesF , SchauB , BacchiegaAB , ShinjoSK . Giant cell arteritis: a multicenter observational study in Brazil. Clinics2013;68(3):317‐22. ">Souza 2013</a> retrospectively reviewed 45 patients with GCA, 32 of whom took aspirin. In analysis aspirin was statistically protective against disease relapse. However, what is not known by the authors is how many of their patients had been on long‐term aspirin prior to the diagnosis of GCA. </p> <p>Others have not found low‐dose aspirin to be advantageous (<a href="./references#CD010453-bbs2-0001" title="BergerCT , WolbersM , MeyerP , DaikelerT , HessC . High incidence of severe ischaemic complications in patients with giant cell arteritis irrespective of platelet count and size, and platelet inhibition. Rheumatology2009;48(3):258‐61. ">Berger 2009</a>; <a href="./references#CD010453-bbs2-0020" title="Gonzalez‐GayMA , PiñeiroA , Gomez‐GigireyA , Garcia‐PorruaC , Pego‐ReigosaR , Dierssen‐SotosT , et al. Influence of traditional risk factors of atherosclerosis in the development of severe ischemic complications in giant cell arteritis. Medicine2004;83(6):342‐7. ">Gonzalez‐Gay 2004</a>; <a href="./references#CD010453-bbs2-0007" title="NarvaezJ , BernadB , Gomez‐VaqueroC , Garcia‐GomezC , Roig‐VilasecaD , JuanolaX , et al. Impact of antiplatelet therapy in the development of severe ischaemic complications and in the outcome of patients with giant cell arteritis. Clinical Experimental Rheumatology2008;26(3 (Suppl 49)):S57‐62. ">Narvaez 2008</a>; <a href="./references#CD010453-bbs2-0047" title="SalvaraniC , Della BellaC , CiminoL , MacchioniP , FormisanoD , BajocchiG , et al. Risk factors for severe cranial ischaemic events in an Italian population‐based cohort of patients with giant cell arteritis. Rheumatology2009;48(3):250‐3. ">Salvarani 2009</a>). <a href="./references#CD010453-bbs2-0001" title="BergerCT , WolbersM , MeyerP , DaikelerT , HessC . High incidence of severe ischaemic complications in patients with giant cell arteritis irrespective of platelet count and size, and platelet inhibition. Rheumatology2009;48(3):258‐61. ">Berger 2009</a> found 26% of their cohort were using aspirin at time of diagnosis of GCA. In their analysis they found no significant association between those who were on aspirin and those who were not in terms of ischaemic complications. Likewise, <a href="./references#CD010453-bbs2-0007" title="NarvaezJ , BernadB , Gomez‐VaqueroC , Garcia‐GomezC , Roig‐VilasecaD , JuanolaX , et al. Impact of antiplatelet therapy in the development of severe ischaemic complications and in the outcome of patients with giant cell arteritis. Clinical Experimental Rheumatology2008;26(3 (Suppl 49)):S57‐62. ">Narvaez 2008</a> did not observe a significant benefit in terms of incidence of ischaemic complications or disease outcome. </p> <p>The use of low‐dose aspirin is common practice and is recommended (<a href="./references#CD010453-bbs2-0015" title="DasguptaB , BorgFA , HassanN , AlexanderL , BarracloughK , BourkeB , et al. BSR and BHPR guidelines for the management of giant cell arteritis. Rheumatology2010;49(8):1594‐7. ">Dasgupta 2010</a>), despite inadequate evidence to support this. The uncertainty of benefit must be weighed up with concerns over the potential morbidity associated with its use, particularly when used concurrently with corticosteroids. A range of haemorrhagic side effects are reported including gastrointestinal haemorrhage and occipital haemorrhage (<a href="./references#CD010453-bbs2-0005" title="LeeMS , SmithSD , GalorA , HoffmanGS . Antiplatelet and anticoagulant therapy in patients with giant cell arteritis. Arthritis and Rheumatism2006;54(10):3306‐9. ">Lee 2006</a>). </p> <p>This review highlights an evidence gap for the potential benefit and harm of concurrent use of aspirin in GCA. Major evidence is required to provide information on whether the theoretical benefit, as investigated by <a href="./references#CD010453-bbs2-0053" title="WeyandCM , KaiserM , YangH , YoungeB , GoronzyJJ . Therapeutic effects of acetylsalicylic acid in giant cell arteritis. Arthritis and Rheumatism2002;46(2):457‐66. ">Weyand 2002</a>, can be translated into a therapeutic benefit. This evidence would be required prior to consideration of recommending a RCT. It is acknowledged that this evidence would be challenging to accrue due to the low incidence of GCA and the relatively low rate of ischaemic complications in the context of prompt immunosuppression. Such treatment studies are likely to require increased national and international collaboration and the formation of networks directed towards increasing our understanding and improving our treatment in GCA. </p> <section id="CD010453-sec-0078"> <h3 class="title" id="CD010453-sec-0078">Summary of main results</h3> <p>No studies met the inclusion criteria for this review. A summary of the current evidence is recorded in <a href="#CD010453-tbl-0001">Table 1</a>. </p> </section> <section id="CD010453-sec-0079"> <h3 class="title" id="CD010453-sec-0079">Overall completeness and applicability of evidence</h3> <p>Our search strategy (outlined earlier) is likely to have returned all relevant articles in this area. Our expert knowledge and handsearching did not return any additional references. We did not identify any relevant non‐English articles. The applicability of this review is limited by the lack of studies of sufficient quality to be included. </p> </section> <section id="CD010453-sec-0080"> <h3 class="title" id="CD010453-sec-0080">Quality of the evidence</h3> <p>No studies met the inclusion criteria for this review. The quality of the available evidence is poor in terms of both methodology and numbers observed. </p> </section> <section id="CD010453-sec-0081"> <h3 class="title" id="CD010453-sec-0081">Potential biases in the review process</h3> <p>We used standard Cochrane systematic review methodology to define the inclusion and exclusion criteria and conduct the searches for this review. Since no studies met the inclusion criteria, further comment is not possible. </p> </section> <section id="CD010453-sec-0082"> <h3 class="title" id="CD010453-sec-0082">Agreements and disagreements with other studies or reviews</h3> <p>We have not found any other reviews investigating aspirin use in GCA.</p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD010453-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010453.pub2/media/CDSR/CD010453/urn:x-wiley:14651858:media:CD010453:CD010453-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010453.pub2/media/CDSR/CD010453/image_t/tCD010453-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Results from searching for studies for inclusion in the review" data-id="CD010453-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010453.pub2/media/CDSR/CD010453/image_n/nCD010453-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Results from searching for studies for inclusion in the review</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010453.pub2/full#CD010453-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010453.pub2/media/CDSR/CD010453/image_n/nCD010453-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table data-id="CD010453-tbl-0001"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Summary of current medical evidence reporting on aspirin use in GCA</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Article</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of participants with GCA</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Methods</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>GCA</b> </p> <p><b>Biopsy‐proven (%)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number on ASA at time of diagnosis</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number started on ASA after diagnosis</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Comment on adjunctive therapy</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Conclusion</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Berger 2009</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>85</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective case series</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>78%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22 participants took ASA treatment prior to GCA diagnosis</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No benefit of established use of ASA on rate of ischaemic complications</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Chuang 1982</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective case series of PMR and GCA</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lee 2006</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>143</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective case series</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>73%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ASA not reported separately</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ASA not reported separately</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60.1% received long‐term antiplatelet or anticoagulation</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16.2% versus 48% had ischaemic complication (P value &lt; 0.0005) in favour of antiplatelet/coagulation</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Liozon 2001</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>174</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prospective observational case series investigating permanent visual loss</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>84.5%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low molecular weight heparin and intravenous heparin were used for visual loss</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Thrombocytosis was strongly associated with risk of permanent visual loss</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Narvaez 2008</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>121</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>73%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30.5% were on ASA and 7% on another antiplatelet agent prior to symptoms/signs of GCA </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No observed benefit of antiplatelet therapy on the incidence of ischaemic complications or disease outcome </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nesher 2004a</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>175</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>87%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>36</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>41</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21% were already using low‐dose ASA at time of GCA diagnosis</p> <p>All given prednisolone at time of GCA diagnosis</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>At diagnosis 8% with ASA had ischaemic complications compared to 29% who did not have ASA (P value = 0.01) </p> <p>At 3 months 3% with ASA had ischaemic complications compared to 13% who did not have ASA (P value = 0.02) </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Souza 2013</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Retrospective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not known</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ASA not reported separately</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ASA not reported separately</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32 (71.1%) were reported on aspirin</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Aspirin was of statistical benefit in preventing relapse (P value = 0.023)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="8"> <div class="table-footnote"> <p>ASA: aspirin<br/> GCA: giant cell arteritis<br/> PMR: polymyalgia rheumatica </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Summary of current medical evidence reporting on aspirin use in GCA</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010453.pub2/full#CD010453-tbl-0001">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD010453.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD010453-note-0003">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD010453-note-0005">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD010453-note-0002">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD010453-note-0001">Hrvatski</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"/> </img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010453\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010453\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010453\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010453\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010453\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010453\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010453\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010453\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010453\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010453\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010453\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010453\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010453\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010453\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010453\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010453\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010453\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010453\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=jxlIh5Me&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010453.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010453.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD010453.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD010453.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010453.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740729673137"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010453.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740729673141"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010453.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918ee2a2ce409377',t:'MTc0MDcyOTY3My4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 